Japan Science and Technology Agency (JST) to Automate Indexing of 90 Journals in SciVerse Scopus

AMSTERDAM, February 16, 2011 /PRNewswire-FirstCall/ -- Elsevier and the Japan Science and Technology Agency (JST) have reached a new agreement for the automated delivery of the metadata of 90 J-STAGE journals in SciVerse Scopus, reflecting the mutual commitment of Elsevier and JST to the global dissemination of scientific research.

"SciVerse Scopus continues to improve indexing peer-reviewed literature, building a global, reliable database. This agreement between Elsevier and JST sets a good example of worldwide recognition of Japanese academic journals," said Ms. Mikiko Tanifuji, General Manager of the Scientific Information Office and Publishing Director of Science and Technology of Advanced Materials at the National Institute for Materials Science in Japan. Ms. Tanifuji sits on the Content Selection Advisory Board for SciVerse Scopus.

JST has been utilizing Scopus custom data to analyze scientific research in Japan at a national level. The indexing of J-STAGE journals in SciVerse Scopus builds upon Elsevier's existing cooperation with JST and will extend further exposure to the research published within those titles to the global academic community. Metadata from J-STAGE will continuously and automatically be indexed within SciVerse Scopus with immediate effect.

"I believe that SciVerse Scopus can make articles on J-STAGE much more visible globally," said Yoshiyuki Miyagawa, Manager, Group of Electronic Journals within the Department of Databases for Information and Knowledge Infrastructure at JST. He added that the uptake of data from J-STAGE to SciVerse Scopus will be made much easier under this new agreement: "It will be a good start for the future relationship between Elsevier and JST as well."

J-STAGE was developed in 1999 to encourage Japanese research societies to publish their academic journals electronically on a central platform. As the world's largest abstract and citation database of peer-reviewed literature, SciVerse Scopus magnifies the mission of J-STAGE to disseminate published research within those journals at a targeted, global level.

About Japan Science and Technology Agency (JST)

Japan Science and Technology Agency (JST) (http://www.jst.go.jp/EN/index.html) aims to establish Japan as a nation built on the creativity of science and technology and innovation, as a core organization for implementing Japan's science and technology policy in line with the objectives of the Science and Technology Basic Plan. JST's mission is to promote science and technology in Japan by conducting a broad range of activities, including the following:

* Promotion of consistent research and development from basic research to commercialization with particular emphasis on the creation of new technological seeds

* Upgrading the infrastructure for the promotion of science and technology, including dissemination of scientific and technological information

About SciVerse Scopus

Covering the world's research literature, SciVerse Scopus (http://www.info.sciverse.com/scopus/) is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. SciVerse Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from over 18,000 peer-reviewed journals from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, SciVerse Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make SciVerse Scopus quicker, easier and more comprehensive to use than any other literature research tool.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell (http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/), Reaxys (http://www.reaxys.com/), MD Consult (http://www.mdconsult.com/) and Nursing Consult ( http://www.nursingconsult.com/), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com/), employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com/), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contacts
    Sandra Plasse/Jennifer Saunders
    +1-212-752-8338
    [email protected]
    [email protected]

SOURCE Elsevier